Nanexa AB
Nanexa redefines injectables using proprietary nanoengineering drug delivery technology.
Yleiskatsaus
- 10–19
- Työntekijät
- 5–10milj SEK
- Liikevaihto
- 2010
- Perustettu
Avainpäättäjät
David Westberg
CEO
Göran Ando
Chairman of the Board
Jonas Fransson
Head of Pharmaceutical Development
Mårten Rooth
CTO
+3 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Nanexa is a pharmaceutical development company specializing in advanced drug delivery systems. Their core innovation is the proprietary PharmaShell® technology, which utilizes Atomic Layer Deposition (ALD) precision. This technology is designed to transform drug administration by enabling long-actin...